Loading clinical trials...
Loading clinical trials...
Effect of Aspirin on Biomarkers of Barrett's Esophagus After Successful Eradication of Barrett's Esophagus With Radiofrequency Ablation
Conditions
Interventions
Aspirin
Laboratory Biomarker Analysis
+2 more
Locations
10
United States
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
UCHealth University of Colorado Hospital
Aurora, Colorado, United States
Northwestern University
Chicago, Illinois, United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Kansas City Veterans Affairs Medical Center
Kansas City, Missouri, United States
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Start Date
January 15, 2016
Primary Completion Date
June 18, 2019
Completion Date
March 17, 2026
Last Updated
October 23, 2025
NCT05733689
NCT04900818
NCT05677490
NCT07282912
NCT06523374
NCT06005493
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions